ERASVSLEXX• 12 Months (Normalized)
ERAS vs LEXX (Erasca Inc. vs Lexaria Bioscience Corp.)
Showing Closing Date Range from Sep 25, 2025 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ERAS Performance $13.95
+670.44%
Erasca Inc.
Normalized Baseline0.00%
LEXX Performance $3.24
-85.9%
Lexaria Bioscience Corp.
Normalized Baseline0.00%
Alpha Spread Margin ERAS LEADS
+756.34 pts
ERAS outperforming by 756.34 percentage points
ERASLEXX
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ERAS LEXX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(250 dates)
| Date | ERAS Price | ERAS Gain (%) | LEXX Price | LEXX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $13.95 | +670.44% | $3.24 | -85.90% | +756.34% |
| Sep 22, 2026 | $15.55 | +759.12% | $- | - | |
| Sep 21, 2026 | $15.04 | +730.94% | $3.43 | -85.08% | +816.02% |
| Sep 18, 2026 | $14.77 | +716.02% | $3.24 | -85.88% | +801.90% |
| Sep 17, 2026 | $15.34 | +747.51% | $3.29 | -85.66% | +833.17% |
| Sep 16, 2026 | $15.36 | +748.62% | $3.10 | -86.51% | +835.13% |
| Sep 15, 2026 | $16.25 | +797.79% | $3.21 | -86.01% | +883.80% |
| Sep 14, 2026 | $16.16 | +792.82% | $3.55 | -84.53% | +877.35% |
| Sep 11, 2026 | $15.88 | +777.35% | $3.97 | -82.70% | +860.05% |
| Sep 10, 2026 | $16.03 | +785.64% | $4.05 | -82.35% | +867.99% |
| Sep 09, 2026 | $15.70 | +767.40% | $6.60 | -71.24% | +838.64% |
| Sep 08, 2026 | $16.28 | +799.45% | $9.37 | -59.17% | +858.62% |
| Sep 04, 2026 | $16.19 | +794.48% | $14.15 | -38.34% | +832.82% |
| Sep 03, 2026 | $16.26 | +798.34% | $12.32 | -46.32% | +844.66% |
| Sep 02, 2026 | $16.37 | +804.42% | $13.21 | -42.46% | +846.88% |
Page 1 of 17